70.46

0.09% 0.06

After Hours: 70.46

Haemonetics Corp (HAE)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Haemonetics Corp stock is traded at $70.46, with a volume of 604.50K. It is up +0.09% in the last 24 hours and up +10.82% over the past month. Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Previous Close:

$70.40

Open:

$71.11

24h Volume:

604.50K

Relative Volume:

0.92

Market Cap:

$3.25B

Revenue:

$1.36B

Net Income/Loss:

$123.81M

P/E Ratio:

29.24

EPS:

2.41

Net Cash Flow:

$20.35M

1W Performance:

+4.06%

1M Performance:

+10.82%

6M Performance:

-13.22%

1Y Performance:

-19.36%

1-Day Range:

$70.45

$71.53

1-Week Range:

$67.07

$71.53

52-Week Range:

$55.30

$94.98

Haemonetics Corp Stock (HAE) Company Profile

Name

Haemonetics Corp

Sector

Healthcare (1170)

Industry

Medical Devices (157)

Phone

(781) 848-7100

Address

125 SUMMER STREET, BOSTON, MA

Employee

3,023

Twitter

@HaemoneticsCorp

Next Earnings Date

2024-11-07

Latest SEC Filings

HAE's Discussions on Twitter

Compare HAE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HAE Haemonetics Corp	70.46	3.25B	1.36B	123.81M	20.35M	2.41
ABT Abbott Laboratories	133.58	232.41B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.09	155.73B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	383.89	146.23B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	87.44	106.37B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	77.52	45.88B	5.54B	4.18B	623.10M	7.00

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-07-25	Downgrade	BofA Securities	Neutral → Underperform
Dec-06-24	Initiated	JP Morgan	Overweight
Nov-08-24	Upgrade	Raymond James	Outperform → Strong Buy
Sep-13-24	Initiated	CL King	Buy
Sep-11-24	Initiated	BofA Securities	Neutral
Sep-10-24	Initiated	BTIG Research	Buy
Jun-12-24	Upgrade	Needham	Hold → Buy
Oct-13-22	Initiated	Mizuho	Buy
Jan-27-22	Downgrade	Needham	Buy → Hold
Dec-15-21	Downgrade	Citigroup	Buy → Neutral
Aug-17-21	Resumed	Raymond James	Outperform
Jun-17-21	Initiated	Citigroup	Buy
May-14-21	Upgrade	CJS Securities	Market Perform → Market Outperform
Apr-20-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-19-21	Downgrade	CJS Securities	Market Outperform → Market Perform
Feb-03-21	Upgrade	Barrington Research	Mkt Perform → Outperform
Jan-21-21	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-05-20	Upgrade	Barrington Research	Mkt Perform → Outperform
May-06-20	Downgrade	Barrington Research	Outperform → Mkt Perform
Mar-31-20	Upgrade	CJS Securities	Market Perform → Market Outperform
Jan-10-20	Initiated	Needham	Buy
Aug-07-19	Reiterated	Barrington Research	Outperform
May-14-19	Upgrade	Raymond James	Mkt Perform → Outperform
May-08-19	Reiterated	Barrington Research	Outperform
Aug-09-18	Reiterated	Barrington Research	Outperform
Feb-07-18	Reiterated	Barrington Research	Outperform
Jan-02-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-08-17	Reiterated	Barrington Research	Outperform
Aug-08-17	Upgrade	Barrington Research	Mkt Perform → Outperform
Jul-13-17	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Feb-07-17	Downgrade	Barrington Research	Outperform → Mkt Perform
Nov-08-16	Upgrade	Barrington Research	Mkt Perform → Outperform
Nov-07-16	Reiterated	The Benchmark Company	Hold
Sep-20-16	Downgrade	CJS Securities	Market Outperform → Market Perform
Aug-15-16	Downgrade	Sidoti	Buy → Neutral
Aug-02-16	Reiterated	Jefferies	Buy
Aug-02-16	Reiterated	The Benchmark Company	Hold

View All

Haemonetics Corp Stock (HAE) Latest News

Jun 01, 2025

Are Investors Undervaluing Haemonetics Corporation (NYSE:HAE) By 36%? - Yahoo Finance

Jun 01, 2025

May 31, 2025

Zacks Research Decreases Earnings Estimates for Haemonetics - Defense World

May 31, 2025

May 30, 2025

Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference - Quantisnow

May 30, 2025

May 22, 2025

Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus

May 22, 2025

May 21, 2025

HAEMONETICS CORP SEC 10-K Report - TradingView

May 21, 2025

May 20, 2025

JMP maintains Haemonetics stock $100 target post-results By Investing.com - Investing.com Canada

May 20, 2025

What 4 Analyst Ratings Have To Say About Haemonetics - Benzinga

May 20, 2025

Haemonetics (HAE) Stock Rating and Price Target Reaffirmed by JMP Securities | HAE Stock News - GuruFocus

May 20, 2025

JMP maintains Haemonetics stock $100 target post-results - Investing.com

May 20, 2025

May 13, 2025

Haemonetics Corporation (NYSE:HAE) Q4 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025

May 12, 2025

HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up - Yahoo Finance

May 12, 2025

Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World

May 12, 2025

May 11, 2025

Haemonetics Corporation Just Beat EPS By 8.7%: Here's What Analysts Think Will Happen Next - Yahoo Finance

May 11, 2025

May 10, 2025

Haemonetics Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance

May 10, 2025

May 09, 2025

Here's What Key Metrics Tell Us About Haemonetics (HAE) Q4 Earnings - Yahoo Finance

May 09, 2025

Raymond James Reiterates Strong Buy on Haemonetics (HAE) with Lo - GuruFocus

May 09, 2025

Raymond James Reiterates Strong Buy on Haemonetics (HAE) with Lowered Price Target | HAE Stock News - GuruFocus

May 09, 2025

Raymond James Adjusts Haemonetics (HAE) Price Target to $105, Ma - GuruFocus

May 09, 2025